Clinical trial
Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics
NCT01459601 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics
- Lead sponsor
- Mashhad University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2012
- Completion date
- February 29, 2012
- Enrollment
- 10 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes type 2